mesalamine has been researched along with Helicobacter Infections in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pylori." | 2.69 | Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. ( Duncan, HD; Green, JR; Pearce, CB; Timmis, L, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez-Grau, Mdel C | 1 |
| Chaparro, M | 1 |
| Díaz, R | 1 |
| Gisbert, JP | 1 |
| Piodi, LP | 1 |
| Bardella, M | 1 |
| Rocchia, C | 1 |
| Cesana, BM | 1 |
| Baldassarri, A | 1 |
| Quatrini, M | 1 |
| Pearce, CB | 1 |
| Duncan, HD | 1 |
| Timmis, L | 1 |
| Green, JR | 1 |
1 trial available for mesalamine and Helicobacter Infections
| Article | Year |
|---|---|
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis, Ulcera | 2000 |
2 other studies available for mesalamine and Helicobacter Infections
| Article | Year |
|---|---|
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; | 2014 |
Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Female; He | 2003 |